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The RHD exposure categories of “low” and
“high” used by Mead et al. and mentioned in the
first column of page 18 (1) are not related to the
categories of “low” and “high” given in the same
paragraph at the top of the second column. The
reader might easily assume that it was Mead et
al. who considered that Jul–Dec 1995 was “a low
exposure period.” This is not so—such a
classification is made by Smith et al.
Further, the reader might assume that it was
the study by Mead et al. that concluded “that
exposure to RHD virus remains a plausible
explanation for increased disease incidence.”
Again this is an inference drawn by Smith et al.
and is the opposite of the conclusion of Mead et al.
The basis of exposure in the study by Mead et
al. is at an individual level—the respondents
were chosen either because they had been
handling rabbits or as controls in determining the
level of disease. In contrast, Smith et al. consider
exposure at a broad environmental level and
disregard whether the respondents had been
handling infected rabbits or not. Actually, more
contact with rabbits occurred during the first half
of the study than during the second.
Smith et al. do not mention the conclusions of
Mead et al.: These neither showed any significant
difference between levels or types of illness in
those exposed and those not exposed to RHD
virus nor demonstrated any association between
the exposure to RHD and number of episodes of
illness in the subsequent 1 to 2 months.
The results of the study by Mead et al. may be
summarized by noting that the average number
of episodes of illness over the 13-month reporting
period was 2.6 for respondents who had not been
exposed to RHD virus, 2.2 for those classified as
having a low level of exposure, and 2.3 for those
classified as having a high level.
The study by Mead et al. concluded that, on
the basis of the health survey and the lack of any
serologic reaction of the respondents, there was
considerable support to the view that RHD virus
is not associated with infection or disease in
humans. The results of the study have been
submitted for publication in a scientific journal.
Reference 31 should refer to the Bureau of
Resource Sciences (not Studies).
C. Mead
Convenor, Rabbit Calicivirus Human Health Study
Group, Department of Health and Family Services,
Canberra, Australia
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Reply to Drs. Capucci, Lavazza, and Mead
To the Editor: We are aware of Capucci and
Lavazza’s excellent work. Indeed, one of the best
characterized calicivirus genomes is that de-
tected in rabbit hemorrhagic disease (RHD);
however, the virus’ infectivity, pathogenesis,
modes of transmission, reservoirs, survival in
nature, host of origin, virulence factors, number
of neutralization serotypes, and multispecies
infectivity are poorly characterized. Propagating
this virus in vitro could provide insight for
addressing questions relevant to caliciviruses
that cannot be propagated in vitro.
We are unclear about the confusion regarding
Norwalk virus and feline calicivirus (FCV). Both
are caliciviruses. Norwalk virus is a human
pathogen. FCV is in a different genus (1) that
includes strains infecting humans (2). We know of
no documented FCV infections in humans nor of
detailed studies to search for such occurrences,
although some evidence suggests the possibility
(3).
Capucci and Lavazza’s remaining questions
address the etiology of RHD, diagnostic reagents,
and possible human infection. They report nine
laboratory workers as antibody negative but do
not report test results on persons at high risk,
such as rabbit farm workers, nor do they mention
having positive control human or primate sera.
Koch’s postulates have been fulfilled for RHD: a
parvovirus was isolated in vitro and was cell-
passaged 15 times; at a second laboratory, the
parvovirus was identified in materials causing
RHD (4,5). In Europe the parvovirus etiology for
RHD was deemed hypothetical but has not been
refuted on a scientific basis. The calicivirus
consistently identified in European materials has
not been isolated in vitro, and Koch’s postulates
have not been fulfilled. Are the parvovirus-
associated outbreaks of RHD in Mexico and
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outbreaks in Europe identical disease manifesta-
tions of two different viruses? Is RHD
multifactorial requiring two or more agents? Is
RHD caused by only a calicivirus or only a
parvovirus? A calicivirus and a parvovirus can be
isolated in vitro from the same fecal sample of a
sick rabbit (N. Keefer, D.E. Skilling, A.W. Smith,
unpub. data).
Our comments on RHD diagnostic assays
referred to those used in Australia (6,7) to screen
humans and experimentally infected animals to
support legalizing the spread of RHD in Australia
and New Zealand.
Public health protection requires prudent
avoidance of pathogens associated with risk of
adverse outcome, not necessarily proof of
causation (8). In this context, human health risk
for RHD goes largely unaddressed. The deliber-
ate introduction of a new disease agent (RHD)
known to cause death in mammals requires
prudence rather than proof of human illness,
especially when the scientific literature includes
reports that the agent has induced antibody
reactions in a wide range of mammalian and
avian species (6).
Mead et al. (9) conclude, “No significant
association between exposure to RCV and
subsequent bouts of sickness could be demon-
strated.”  Their recorded data do not support a
statistically significant risk of illness because
sample sizes in the monthly groups were too
small for any meaningful interpretation. Mead et
al. (9) state a “lack of any serologic reaction of the
respondents,” but a 50% cut-point was used for
the competitive ELISA test, and some individual
sera were repeated up to six times with percent
inhibition reactions ranging from approximately
1% to 44% in one instance and 12% to 100% in
another. Results were selected from these
laboratory data and reported “lack of serologic
reaction.”
We derived our findings from data obtained
under a freedom of information request. Mead et
al. used the same data to support an opposite
conclusion. Opposing conclusions “red flag” the
quality of the study. In summary, the reporting of
negative results of such a study cannot be used to
support the important biologic, health, and
political conclusion that humans are not at risk
from infection with RHD.
We encourage a well-designed longitudinal
study of persons at high risk of RHD exposure to
answer conclusively whether RHD has infected
humans. If “the rule” means that most humans
exposed to RHD would become infected, we agree
with Dr. Capucci “that infection is unlikely to be
the rule,” but transmission of equine morbillivirus,
Rift Valley fever, and H5N1 influenza to humans
is also “unlikely to be the rule” (10).
Alvin W. Smith,* Neil J. Cherry,† and
David O. Matson‡
*Oregon State University, Corvallis, Oregon, USA;
†Lincoln University, Christchurch, New Zealand;
‡Center for Pediatric Research, Norfolk,
Virginia, USA
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